Optimal hepatobiliary scintigraphy for gallbladder dyskinesia. [PDF]
Surg Open Sci, 2021 Background: The accuracy of hepatobiliary scintigraphy to assess gallbladder function remains controversial. National supply shortages of pharmaceutical-grade cholecystokinin led to the use of an oral fatty meal to stimulate gallbladder contraction ...
Flick KF +6 more
europepmc +3 more sources
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms. [PDF]
BiomoleculesPeptides continue to gain significance in the pharmaceutical arena. Since the unveiling of insulin in 1921, the Food and Drug Administration (FDA) has authorised around 100 peptides for various applications.
Al Musaimi O.
europepmc +3 more sources
Sincalide-Stimulated Cholescintigraphy: What Is the Standard? [PDF]
Journal of Nuclear Medicine, 2010 TO THE EDITOR: The article by Ziessman et al. adds to the further understanding of gallbladder physiology and the effect of cholecystokinin (CCK) stimulation ( [1][1] ). They suggest considering a 38% gallbladder ejection fraction (GBEF) as the lower limit of normal for a 0.02 μg/kg infusion of ...
Gerbail T, Krishnamurthy +1 more
openaire +2 more sources
Cholecystokinetic cholecystography: efficacy and tolerance study of sincalide [PDF]
American Journal of Roentgenology, 1976 The intravenous administration of sincalide, the C-terminal octapeptide fragment of cholecystokinin, affords safe and effective means for gallbladder contraction with resultant cystic and common bile duct visualization. Intravenous sincalide circumvents the problem of unpredictability of response of the gallbladder to a fatty meal and variability in ...
E N, Sargent, H I, Meyers, J, Hubsher
openaire +2 more sources
Nanochanneled Device and Related Methods [PDF]
, 2013 A capsule configured for in vivo refilling of a therapeutic agent.
Ferrari, Mauro +4 more
core +5 more sources
Ursodiol in Patients with Parenteral Nutrition–Associated Cholestasis [PDF]
, 2007 OBJECTIVE To review the role of ursodeoxycholic acid (ursodiol) in treating parenteral nutrition–associated cholestasis (PNAC). DATA SOURCES A MEDLINE (1950–May 2007) search was performed using the key terms parenteral nutrition, cholestasis ...
Btaiche, Imad F., San Luis, Valerie A.
core +1 more source
Gallbladder Ejection Fraction is Unrelated to Gallbladder Pathology in Children and Adolescents [PDF]
, 2016 Objectives: Biliary dyskinesia is a common diagnosis that frequently results in cholecystectomy. In adults, most clinicians use a cut off value for the gallbladder ejection fraction (GBEF) of
Bennett, William E. +4 more
core +1 more source
Involvement of cannabinoid signaling in vincristine-induced gastrointestinal dysmotility in the rat [PDF]
, 2017 [Background]: In different models of paralytic ileus, cannabinoid receptors are overexpressed and endogenous cannabinoids are massively released, contributing to gastrointestinal dysmotility.
Abalo, Raquel +5 more
core +1 more source
Use of Cholecystokinin to Prevent the Development of Parenteral Nutritionâ Associated Cholestasis [PDF]
, 1997 Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/142290/1/jpen0100 ...
Bayar, Bilge +7 more
core +1 more source
Variabilities of gallbladder contraction indices and a simple regression model for gallbladder and gastric emptying ratio [PDF]
, 2011 Introduction: The objective of this study was to assess the variabilities of gallbladder contraction indices (GBCI) and derive a predictive model for gallbladder and gastric motility.
Agwu, KK, Erondu, OF, Ugwu, AC
core +2 more sources